Analyzing the Impact of Covid-19 And Solvency Ratios on the Profitability of Indian Pharma Companies

The present research work studies about the impact of Covid-19 and solvency ratios impact on the profitability of Indian pharma companies. This particular study has been conducted for the period of 11 years from 2013 to 2023 with the data set of 110 observations for 10 pharma companies which are registered under BSE (Bombay stock Exchange) and NSE (National Stock Exchange) of India. The four independent variables are Covid, Current ratio, Debt to equity ratio and Interest coverage ratio and the dependent variable as Return on Net worth have been tested using the Panel Data Analysis and Exploratory Data Analysis as statistical tools. The results suggested that covid doesn’t have any impact on the profit of the selected firms where as other three independent variables have impact on profitability of Indian pharma companies. The present research work studies about the impact of Covid-19 and solvency ratios impact on the profitability of Indian pharma companies. This particular study has been conducted for the period of 11 years from 2013 to 2023 with the data set of 110 observations for 10 pharma companies which are registered under BSE (Bombay stock Exchange) and NSE (National Stock Exchange) of India. The four independent variables are Covid, Current ratio, Debt to equity ratio and Interest coverage ratio and the dependent variable as Return on Net worth have been tested using the Panel Data Analysis and Exploratory Data Analysis as statistical tools. The results suggested that covid doesn’t have any impact on the profit of the selected firms where as other three independent variables have impact on profitability of Indian pharma companies.